|
|
PROGRAMMING HUMAN CHAPERONE SYSTEMS AGAINST NEURODEGENERATIVE DISEASE |
| 1F32NS108598-01A1 |
BARBIERI, EDWARD |
NINDS |
2019 |
|
|
NOVEL PATHWAYS IN C9ORF72-ASSOCIATED ALS AND DEMENTIA |
| 1K08NS104270-01A1 |
MORDES, DANIEL ADAM |
NINDS |
2019 |
|
|
STUDYING AGGREGATION IN NEURODEGENERATIVE DISEASE USING SYNTHETIC PROTEINS |
| 1R01NS103873-01A1 |
PETERSSON, ERNEST JAMES |
NINDS |
2019 |
|
|
GENOME-WIDE PREDICTION OF DEMENTIA IN PARKINSON DISEASE |
| 1R01NS115144-01 |
SCHERZER, CLEMENS R |
NINDS |
2019 |
|
|
2019 AMERICAN SOCIETY FOR NEURAL THERAPY AND REPAIR |
| 1R13NS111902-01 |
FINK, KYLE |
NINDS |
2019 |
|
|
FASEB SRC ON PROTEIN AGGREGATION, FROM STRUCTURAL VARIANTS TO IN VIVO SEQUELA |
| 1R13NS111914-01 |
SIGURDSON, CHRISTINA |
NINDS |
2019 |
|
|
PHARMACOLOGIC INHIBITION OF RIBONUCLEOPROTEIN DROPLET MATURATION |
| 1R21NS109678-01A1 |
FERREON, ALLAN CHRIS |
NINDS |
2019 |
|
|
TARGETING NEUROTOXIC ALPHA-SYNUCLEIN AGGREGATES FOR PARKINSON'S DISEASE THERAPY. |
| 1R41NS113694-01 |
LASMEZAS, CORINNE IDA |
NINDS |
2019 |
|
|
MECHANISMS OF CATECHOLAMINERGIC NEURODEGENERATION |
| 1ZIANS003033-13 |
GOLDSTEIN, DAVID |
NINDS |
2019 |
|
|
BIOMARKERS OF CATECHOLAMINERGIC NEURODEGENERATION |
| 1ZIANS003034-13 |
GOLDSTEIN, DAVID |
NINDS |
2019 |
